These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
902 related items for PubMed ID: 18957615
21. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism. Dewailly D, Pigny P, Soudan B, Catteau-Jonard S, Decanter C, Poncelet E, Duhamel A. J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596 [Abstract] [Full Text] [Related]
30. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study. Homburg R, Ray A, Bhide P, Gudi A, Shah A, Timms P, Grayson K. Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771 [Abstract] [Full Text] [Related]
35. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis. Lie Fong S, Laven JSE, Duhamel A, Dewailly D. Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584 [Abstract] [Full Text] [Related]
36. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. J Clin Endocrinol Metab; 2004 Jan 01; 89(1):318-23. PubMed ID: 14715867 [Abstract] [Full Text] [Related]
37. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results. Yetim A, Yetim Ç, Baş F, Erol OB, Çığ G, Uçar A, Darendeliler F. J Clin Res Pediatr Endocrinol; 2016 Sep 01; 8(3):288-97. PubMed ID: 27125339 [Abstract] [Full Text] [Related]
38. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome. Yang HY, Ma Y, Lu XH, Liang XH, Suo YJ, Huang ZX, Lu DC, Qin YF, Luo ZJ. Ann Endocrinol (Paris); 2015 Oct 01; 76(5):620-7. PubMed ID: 26514948 [Abstract] [Full Text] [Related]
39. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Holte J, Bergh T, Gennarelli G, Wide L. Clin Endocrinol (Oxf); 1994 Oct 01; 41(4):473-81. PubMed ID: 7955458 [Abstract] [Full Text] [Related]
40. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome. Sahmay S, Atakul N, Oncul M, Tuten A, Aydogan B, Seyisoglu H. Eur J Obstet Gynecol Reprod Biol; 2013 Sep 01; 170(1):157-61. PubMed ID: 23806449 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]